Block 2_2 - Histamine Flashcards
Describe synthesis of Histamine
- cofactors?
Histidine —Histadine Decarboxylase—-> Histamine
(essential amino acid L-histidine)
- histidine decarboxylase uses pyridoxal-5-phosphate as cofactor
- inhibited by methyl-histidine
Name the 2 histamine degrading enzymes
Diamine oxidase (DAO)
Histamine-N-methyl transferase (HNMT)
Histamine General Uses (3)
- Mediator of immediate allergic and inflammatory reactions
- role in gastric acid secretion
- neurotransmitter and neuromodulator
Highest source of Histamine
ubiquitous
- lung, skin and stomach
Localization of Histamine
“Pools” of Histamine located where?
- In tissues - mast cells
- In blood - Basophils
- Non-mast cells (gastric mucosa cells, epidermis, neurons)
Histamine in Tissues (mast cells) and Blood (basophils)
- Synthesized and stored?
- Turnover?
- synthesized and stored in secretory granules in an inactive form; bound to a proteoglycan
- herpain-sulfate and ATP: mast cells
- chondroitin-sulfate: basophils - Slow turnover in mast cells
Histamine in non-mast cells
- Synthesis and storage? Turnover?
- levels of histamine
- no granules, continuously synthesized and releeased, rapid turnover
- correlate with activity of histidine decarboxylase (inducible enzyme)
Release of Histamine - Antigen-Antibody Reaction
2 steps?
a) ___ dependent
b) releases other _____ as well
- Induction of IgE-mediated allergic sensitivity to drugs and other allergens
- IgE antibody produced and fixed to mast cells and blood basophils - Response of IgE-sensitized cells to subsequent exposure to allergens.
a) Ca2+
b) mediators
- Effect of Histamine Release (or after injection) within seconds
- within minutes
- experience burning, itching sensation, most marked in palms of hand, in the face, scalp, and ears followed by intense warmth. Skin reddens, blood pressure falls, HR increases, headaches are common
- BP recovers and hives will appear on skin
Drugs, Peptides, Venoms that promote the release of histamine
- Antigen-antibody mediated release?
- Direct or Indirect Stimulation?
- Drug Examples
- Peptide Examples
- Venom Examples
- Mechanism of action
- No
- Direct Stimulation without prior exposure (CLINICAL CONCERN)
- Succinylcholine, morphine, curare, certain carbohydrate plasma expanders (dextran, PVP), some antibiotics (Vancomycin-induced “red-man syndrome”)
- Substance P; complement (C3a, C5a)
- wasp venom
- increase intracellular Ca2+ via a number of different pathways
Red-man (red neck, red person) Syndrome
1a-c. Cause
- Seen following?
- Physical Presentation
- Physiologic Effect
1a. Vancomycin
- Gram-positive bacteria
- last resort antibiotic
- serious gram positive infections
1b. Mast cell degranulation (not allergic reaction to vancomycin)
1c. altered histamine metabolism
2. Following rapid IV infusion
3. Rash in face, neck, upper torso
4. Hypotension
Other stimuli that release histamine (4)
- Cold urticaria (hives)
- Cholinergic urticaria
- increased sympathetic nervous activity (seen with exercise, stress) stimulates cholinergic fibers innervating sweat glands to release Ach, leading to mast cell degranulation - Solar urticaria
- nonspecific cell damage
Agents which INHIBIT the release of histamine (6)
- Cromolyn sodium
- Omalizumab
- ß-adrenoreceptor agonists
- Methylxanthines
- Corticosteroids used for asthma treatment
- Histamine inhibits its own release
**Cromolyn sodium **
- Mechanism of action
- Route of Admin
- Use
- Side Effects
- Stabilizes mast cell membrane to prevent release of histamine
- no mast cell degranulation
- exact cellular/molecular mechanism is not clear
- Inhalation (mainly)
- others: oral, nasal, ophthalmic - inhaled anti-inflammatory agent
- preventive management of asthma (chronic control)
- prophylaxis of bronchospasm (allergen- or exercise-induced)
- Not a rescue medicine!
- allergies, allergic rhinitis (Nasal formulation)
- conjunctivitis (Ophthalmic formulation)
- Systemic mastocytosis (oral formulation)
- Off-label uses for food allergy an irritable bowel syndrome (IBS)
- Safe drug with few side effects
Omalizumab
- Mechanism of action
- Route of Admin
- Use
- Side Effects
Monoclonal antibody
- Decreases amount of antigen specific IgE that normally binds to and sensitizes mast cells
- “anti-antibody antibody” - monospecific anti-IgE antibody
- an IgG antibody for which the antigen is the Fc Region of the IgE antibody
- binds tightly to free IgE in the circulation to form omalizumab-IgE complexes
- so no affinity for the FcRI (receptor for Fc)
- Subcutaneous administration (2-4 weeks)
- moderate to severe, persistent allergic asthma not adequately controlled with inhaled corticosteroids
* used as a last resort drug - life threatening anaphylaxis
- bleeding-related adverse effects
ß Adrenoreceptor agonists - Mechanism of action
stimulate adenylyl cyclase which increases cAMP